April 27, 2023 10:47 AM EDTUpdated April 28, 02:53 PM
Deals
Diagnostics

Quest Di­ag­nos­tics buys Bert Vo­gel­stein’s Haystack On­col­o­gy, just six months af­ter Se­ries A

Lei Lei Wu

News Reporter

Quest Di­ag­nos­tics is buy­ing can­cer de­tec­tion start­up Haystack On­col­o­gy for $300 mil­lion in cash, with plans to launch a new can­cer lab test in 2024 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times